Market cap = 1/50 of MKND -- market inefficiency big time here.
Hang on ... Broader set of people who know value will be exposed to AMBS this morning at ICV Manhattan. The Alz drug announcement today is also a really good solution for ADHD/ADD. Skin substitute, ESS is a separate value prop of equal or greater magnitude.
Yesterday blew through 4 week from 50% off low (0.76) to 38% from high (0.88) to high ($1.30) to settle at 13 week ladder wrong 50% from 13 week high. Today 1.75 and 2.70 are key numbers -- -38% from 13 week high and 13 week high -- then next stop = $5.92 -- 38% off 52 week low! 52 week high ($15) still only values this @ $300 million total... Can run much higher and quickly too!
Just picking up steam though. If it had the same market cap as MNKD -- it would be 35x higher than where it is now ($50/share with 14 million shares out = $700mm. Current MNKD = $730 mm cap). MNKD has 1 drug. AMBS has 3 main ones (ESS, Eltorpazine, MANF and Phenogard discovery line and Lab division that can spin out on its own for more than the company is worth today!) GLTA
A key characteristic of this drug is that it does not require a special prescription like amphetamines (ritalin). Much easier for patient and doctor -- prescription can get called in vs having to be a physical script or special highly secure electronic transaction.
AMBS is speaking to reps of high net worth families today. meeting with potential investors / partners in China soon too as invited participant. Study today on drug for Alzheimer is a huge deal and its not even the top drug for AMBS. at a share price of $1.50, whole company cap - with current shares out = $21 million. Alz drug (that is also useful for ADHD/ADD in adults and will not require a special restricted prescription that is necessary for amphetamine stimulants - the current main treatent for ADHD) can support a Billion plus Market Cap (50x current cap). THAT's NOT COUNTING CONTRIBUTION OF skin substitute ESS or MANF that rescues stressed and dying cells at all!!! GLTA. Time to get on board if u want to participate in run up.
Sentiment: Strong Buy
Didn't forget, am well aware of split. Math above is about Market cap. Yes, a 150:1 split occurred & today's highest ever volume would have been 300 million shares pre-split. Very strong having highest volume ever (whether calling it 2 million shares today or 300 million pre split) on a day when the stock is up 91% to a market cap of $20 million TOTAL MARKET CAP. Currently $20 million -- way under priced. Dx division has real value. China partner potential is real - they are an invited guest at Chinese gathering to create partnerships -- that is happening this week.
Still a great deal at 1.50 --- Market cap $21 million. 3 great compounds with billion dollar potential. MNKD with 1 compound has market cap of $730 million. Investor conference in Manhattan tomorrow and China in the following few days -- Army project on skin for burns running forward. GLTA -- It's a strong discount still.
Stock with about 14 million shares out -- now trading at a Cap of -- $20 million (as of 12/7. It was under 5 million a week or so ago). Any of its 3 main drugs could EACH be a billion $ revenue / yr drug and support a north of 8 figure market cap. So conservatively this really should be 5-10x current price of $1.40 ($100 to $200 million cap) and could easily go up from there. As an example - MNKD has a market cap of $730 million right now (35x AMBS) and has only 1 main compound, not 3... There are lots of other examples of why this is a great deal right now. Near term drivers include...
1) Moving up because Holders of convertibles agreed to not convert until after end of year.
2) Moving up because of good investor presentations recently and ongoing - more people finding out how cheap it is -- Has another presentation on the 8th (tomorrow) - ICV manhattan
3) Any of the drugs - ESS, MANF, & the ADD/ADHD drug can easily support the market cap.
4) Spinning off the lab business can pay the freight to get the drugs to market.
5) Potential of Chinese partner in the near term -- when current market sentiment is that Chinese $ are looking to partner and / or invest in out of China assets (see new york real estate discussions for example) - Presenting in China as invited partner in the next few days.
Yes - it is going up. It's gone up multiples from last week to this. It's a stock that could easily go up mulitples from this week to next as well. Look at key check points technically of $1.16, 1.45, 1.74, 2.70, 5.92 and 7.68 --- should be a fun few weeks!
ESS gaining clinical momentum (past and present leadership of the American Burn Assoc -- Highly respected physicians who want to see this excellent clinical product with a 10 year research track record get into general clinical care (needs FDA approval, has trials moving. has Army funding work too)
Hope you make tons on AMBS, augustussamsoni.
It's been quite a ride. I am confused how you know since Yahoo says your name was born today Dec 7.
Many of us have been tracking this for a long time - down and now up. Value of the product has always been there. In fact, AMBS has a much stronger portfolio now than historically.
at least you'll be back to break even within a short period -- what a rollercoaster though. I had a bunch from pre-split & got hammered. Lucked out & had some cash come my way when stock cratered. Moved avg price from $3 to
ICV Manhattan is a premier event providing a highly selective forum for approximately 50 chief executives at innovative growth companies to meet and share ideas with members of ICV's prestigious investment community. This two-day event will allow family office and fund investors to capitalize on new ideas and businesses that are transforming the shape of their respective industries. In addition to company presentations, experts will discuss the current landscape of their fields through participation in thought leader panels and roundtable discussions. For more information, please visit
Given that the "ipatracker" name is brand new as of today and the sentiment is negative, I'm guessing there is some reason the person behind the ID (or an associate) wants the stock to go down? Anyone have ideas as to why?
I guess we each have to figure out our own comfort & comfort level with info we have. good luck to you.
Long time long here.... Was lucky to have some free cash available when it cratered. Definitely learned a big time lesson about dilutive financing -- I suspect there are others out there too who learned the hard way -- My posts are to let folks know the math so they can make their own decisions. ESS, MANF and ADHD drug are all big time winners. Selling lab division = way to raise cash. All is aligned now that the financiers have pledged to hold off conversions until after the first of the year.
1.5 million shares so far today is equivalent to 225,000,000 shares pre split... Today's price of 1.22 is equivalent to less than $.01 pre split. The stock used to hang out as a low at 2 cents and mid place of 5 cents --- That's 2x and 5x where it is right now...
Sentiment: Strong Buy
Beautiful head and shoulders forming with left shoulder at $1.30 @ 11.30 this morning and now right shoulder forming as volume is increasing (1/2 the vol between 1 and 2.30 in the last few minutes).
Sentiment: Strong Buy